Schools and enterprises join hands to create a new chapter in pet stem cell therapy

Schools and enterprises join hands to create a new chapter of pet stem cell therapy

——The first international pet stem cell (100 Euro-pet stem cells) conference was successfully held in Yang Ling

Stem cell biological technology has made significant progress in the prevention and control of human and pet diseases. More and more studies have shown that future biomedicine is the era of cell therapy.

The first international pet stem cell conference site

On August 18th, the first international pet stem cells (100-Euro-pet stem cells) conference hosted by the Northwest Agricultural and Forestry University of Agriculture and Forestry University of Agriculture and Forestry and the Shaanxi Provincial Stem Cell Engineering Technology Research Center was held in Yangling, Shaanxi.

This conference is carried out in a combination of online and offline, and the theme of the application of pet stem cells, the application of multiple pet stem cells in the treatment of clinical diseases, the development and standard formulation of clinical preparations of stem cells, and the formulation of standards. More than 200 experts and scholars in the fields of stem cells such as China, the United States, Australia, Germany, France, Egypt, etc. attended the meeting, of which 24 high -level scholars conducted two days of academic exchanges on the cutting -edge of pet stem cell research, progress and clinical transformation.

Australian stem cell research expert PROF. KULDIP S. SIDHU as an online report

The purpose of this meeting is to conduct in -depth academic exchanges with high -level scholars in the field of stem cells to attract more excellent scientific researchers, entrepreneurs, and young scholars to pay more attention to the development of the field, actively participate in stem cell research, and serve the pet industry. The prevention and control of domestic livestock and major human illnesses lays the foundation and provides technical guarantee. The convening of this meeting is not only an academic feast in the field of pet stem cells, but also a rare opportunity to communicate with the pet medical industry. It will help promote the development of my country's animals and human health and related disciplines and industries.

In recent years, the study of pet stem cells has flourished. Regenerative medical technology with stem cell therapy as the core has been increasingly affirmed in the treatment of pet diseases. Stem cell therapy has also become one of the most valued cutting -edge areas of life science. As a safe and effective treatment technology, pet stem cells have not only become the research hotspots of scientists, but also are highly valued and supported by governments from various countries.

It is understood that in 2021, Northwestern Agriculture and Forestry University of Agriculture and Forestry and Tianjin Bio Pai Biotechnology Co., Ltd. jointly established the Northwest Agricultural and Forestry Science and Technology University-Bio School Pet Stem Cell Research Institute to build a platform for further strengthening the application and transformation of stem cells and high-level talents. The hospital has achieved remarkable results in scientific research, talent training, social services and international cooperation, and has done a lot of basic research in animal and human stem cell research.

The meeting was hosted by the Northwest Agricultural and Forestry University of Agricultural and Forestry, hosted by the Northwest University of Agriculture and Forestry University of Agricultural and Forestry Science and Technology and the Shaanxi Provincial Stem Cell Engineering Technology Research Center, co -organized by the 100 -Euroist (Tianjin) Biotechnology Co., Ltd. In addition to inviting relevant experts to make the theme report, the meeting also demonstrated the latest achievements in the field of pet stem cells, and organized pet medical and health care companies such as related instruments and equipment, pharmaceutical equipment, and other pet medical companies.

Reporter: Li Yuqiang Jiawei

Edit: Zhao Taozi

- END -